Sun, Sep 21, 2014, 3:39 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

GoPro, Inc. Message Board

  • buz_idea20 buz_idea20 Feb 15, 2012 10:19 AM Flag

    A strategic alliance with Gen-Probe

    DiagnoCure (TSX: CUR.TO - News) is a life sciences company that develops and commercializes high-value cancer diagnostic tests that increase clinician and patient confidence in making critical treatment decisions. In 2008, the Company launched the PrevistageTM GCC Colorectal Cancer Staging Test through its U.S. CLIA laboratory, and granted the worldwide exclusive rights to this test to Signal Genetics in June 2011. The Company also has a strategic alliance with Gen-Probe (NASDAQ: GPRO - News) for the development and commercialization of a second-generation prostate cancer test using PCA3, DiagnoCure's proprietary molecular biomarker. The PROGENSA® PCA3 test is commercialized in Europe under CE mark and is now approved for commercialization in Canada and the United States. For more information, visit

 
GPRO
67.20+0.87(+1.31%)Sep 19 4:15 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.